Protalix BioTherapeutics Aktie
WKN DE: A0ML0E / ISIN: US74365A1016
09.08.2018 13:20:21
|
EARNINGS SUMMARY: Details of Protalix BioTherapeutics Inc. Q2 Earnings Report
(RTTNews) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):
-Earnings: -$11.29 million in Q2 vs. $0.45 million in the same period last year. -EPS: -$0.08 in Q2 vs. -$0.06 in the same period last year. -Analysts projected -$0.06 per share -Revenue: $2.01 million in Q2 vs. $6.36 million in the same period last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Protalix BioTherapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |